JPH0554489B2 - - Google Patents

Info

Publication number
JPH0554489B2
JPH0554489B2 JP60085439A JP8543985A JPH0554489B2 JP H0554489 B2 JPH0554489 B2 JP H0554489B2 JP 60085439 A JP60085439 A JP 60085439A JP 8543985 A JP8543985 A JP 8543985A JP H0554489 B2 JPH0554489 B2 JP H0554489B2
Authority
JP
Japan
Prior art keywords
formula
hpd
mixture
reaction
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60085439A
Other languages
Japanese (ja)
Other versions
JPS61246232A (en
Inventor
Katsukyo Sakurai
Kyochika Tokuyasu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Seikagaku Corp
Original Assignee
Seikagaku Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seikagaku Corp filed Critical Seikagaku Corp
Priority to JP60085439A priority Critical patent/JPS61246232A/en
Publication of JPS61246232A publication Critical patent/JPS61246232A/en
Publication of JPH0554489B2 publication Critical patent/JPH0554489B2/ja
Granted legal-status Critical Current

Links

Description

【発明の詳細な説明】 [産業上の利用分野] 本発明は、ポルフイリンポリマーの製造法に関
し、更に詳しくは、癌の診断・治療に有用なポル
フイリンポリマーの製造法に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing a porphyrin polymer, and more particularly to a method for producing a porphyrin polymer useful for diagnosis and treatment of cancer.

[従来技術及びその問題点] 癌の診断・治療の手段として、最近脚光をあび
てきたものの一つに光感受性物質とレーザー光線
を用いる方法がある。この方法は、癌細胞に新和
性を有する光感受性物質を静脈内投与し、癌細胞
に蓄積させた後、レーザー光線を照射し、物理化
学反応を惹起させることによつて癌組織を診断・
治療するものである(加藤治文他;臨床外科,37
(4),517(1982))。ここで使用される光感受性物質
としては、古くからヘマトポルフイリンなどが知
られていたが、その後、腫瘍局在性の改善された
ヘマトポルフイリン誘導体(以下「HpD」とい
う)が開発された(R.L.Lipson,et al.;Arch.
Dermatol.,82,508(1960):T.J.Dougherty,et
al.,Cancer Research,38,2628(1978))。
[Prior art and its problems] One of the methods that has recently attracted attention as a means of diagnosing and treating cancer is a method using a photosensitizer and a laser beam. This method involves intravenously administering a photosensitizing substance that has novel affinity to cancer cells, allowing it to accumulate in the cancer cells, and then irradiating it with a laser beam to induce a physicochemical reaction, thereby diagnosing and diagnosing cancer tissue.
(Harufumi Kato et al.; Clinical Surgery, 37
(4), 517 (1982)). Hematoporphyrin has long been known as the photosensitizer used here, but later, hematoporphyrin derivatives (hereinafter referred to as "HpD") with improved tumor localization were developed ( RLLipson, et al.; Arch.
Dermatol., 82 , 508 (1960): TJ Dougherty, et.
al., Cancer Research, 38 , 2628 (1978)).

しかし、HpDは電気泳動で数種の化合物から
なる混合物であることが確認されており、正常細
胞にも取り込まれることが知られている。また、
HpDの腫瘍内結合部位や分布状態については
種々問題があり、光化学反応の発生が不均一で充
分な光照射によつても腫瘍残存の可能性が知られ
ている(久住治夫他;医学のあゆみ,132,107
(1985))。更に、HpDは充分な感受性、例えば蛍
光強度、電子スピン共鳴吸収(以下「ESR」と
いう)、を与えるには、多量に使用する必要があ
り、腫瘍細胞のみならず、正常細胞にも多量に取
り込まれて日光過敏症などの副作用を有する。
However, HpD has been confirmed by electrophoresis to be a mixture of several compounds, and is known to be taken up by normal cells. Also,
There are various problems regarding the intratumoral binding site and distribution state of HpD, and it is known that the occurrence of photochemical reactions is uneven and there is a possibility that the tumor may persist even with sufficient light irradiation (Haruo Kusumi et al.; History of Medicine , 132 , 107
(1985)). Furthermore, HpD must be used in large amounts to provide sufficient sensitivity, such as fluorescence intensity and electron spin resonance absorption (hereinafter referred to as "ESR"), and it is difficult for HpD to be taken up in large amounts not only by tumor cells but also by normal cells. It has side effects such as sun sensitivity.

一方、HpDを腫瘍の診断に用いた場合に、
580nmにピークを有する正常粘膜の有する自家蛍
光がHpDの特異蛍光である630nmに重複してい
るために、微細病変での正常領域との境界が不明
瞭となり、正確な診断ができない等の問題がある
(加藤治文他;臨床外科,37,517,(1982))。ま
た、in vitroで腫瘍の診断に用いた場合には、そ
の再現性に問題がある。
On the other hand, when HpD is used for tumor diagnosis,
Because the autofluorescence of normal mucosa, which has a peak at 580 nm, overlaps with the specific fluorescence of HpD at 630 nm, the boundaries between fine lesions and normal areas become unclear, leading to problems such as inability to make accurate diagnoses. Yes (Harufumi Kato et al., Clinical Surgery, 37 , 517, (1982)). Furthermore, when used in vitro for tumor diagnosis, there are problems with reproducibility.

そこで、本発明者らは、低用量で充分な感受性
を与え、腫瘍細胞に特異的な親和性を有する安全
性の高い光感受性物質を見出すべく鋭意研究を重
ねた結果、本発明を完成するに至つた。
Therefore, the present inventors have conducted intensive research to find a highly safe photosensitizer that provides sufficient sensitivity at a low dose and has a specific affinity for tumor cells, and as a result, they have completed the present invention. I've reached it.

[発明の構成] 本発明は、 次式(): (式中、Y及びZは、同一でも異なつていても
よく、それぞれ−CH(CH3)OH又は−CH=
CH2を表わす。) で示される化合物からなる群から選ばれた1種の
化合物又は2種以上の化合物の混合物を有機溶媒
中において、光と酸素を遮断して40〜200℃で加
熱反応させることを特徴とするポルフイリンポリ
マーの製造法に関するものである。
[Structure of the Invention] The present invention has the following formula (): (In the formula, Y and Z may be the same or different, and each represents -CH( CH3 )OH or -CH=
Represents CH2 . ) is characterized by heating and reacting one compound or a mixture of two or more compounds selected from the group consisting of the compounds shown in an organic solvent at 40 to 200°C while blocking light and oxygen. This invention relates to a method for producing porphyrin polymers.

前記式()で示される化合物の具体例として
は、ヘマトポルフイリン(以下「Hp」という)、
プロトポルフイリン(以下「Pp」という)、及び
7(12)−(1−ヒドロキシエチル)−12(7)−ビニルジ
ユーテロポルフイリン異性体などが挙げられる。
また、用いる有機溶媒としては、酢酸、ジメチル
ホルムアミド、ジメチルスルホキシドなどが挙げ
られる。
Specific examples of the compound represented by the formula () include hematoporphyrin (hereinafter referred to as "Hp"),
Examples include protoporphyrin (hereinafter referred to as "Pp"), and 7(12)-(1-hydroxyethyl)-12(7)-vinyldeuteroporphyrin isomers.
Further, examples of the organic solvent used include acetic acid, dimethylformamide, dimethyl sulfoxide, and the like.

本発明の製造法は、酸の存在下及び不存在下の
いずれにおいても行うことができる。酸の不存在
下に反応を行う場合、100〜150℃で加熱反応させ
ることが好ましい。この場合の反応時間は、通常
30分〜78時間である。酸の存在下に反応を行う場
合、酸としては、例えば濃硫酸又は塩化水素が挙
げられる。この場合の反応時間は、通常5分〜78
時間である。
The production method of the present invention can be carried out either in the presence or absence of an acid. When the reaction is carried out in the absence of an acid, it is preferable to heat the reaction at 100 to 150°C. The reaction time in this case is usually
30 minutes to 78 hours. When the reaction is carried out in the presence of an acid, examples of the acid include concentrated sulfuric acid or hydrogen chloride. The reaction time in this case is usually 5 minutes to 78
It's time.

反応温度が前記下限未満であると、生成物の重
合度が不充分となり、癌細胞に結合した場合に充
分な光感受性を示すことができない。
If the reaction temperature is below the lower limit, the degree of polymerization of the product will be insufficient and it will not be able to exhibit sufficient photosensitivity when bound to cancer cells.

反応終了後、反応液に多量の水を加え、PHを
2.5〜4.0に調整すると沈殿物が生じるので、これ
を取し充分に水洗して有機溶媒を除去する。得
られた粉末を0.1N水酸化ナトリウム水溶液に溶
解し、5〜60分室温で放置後、PHを7.0〜7.5に調
整し、分画分子量約5000の限外過膜を用いて低
分子量部分を除去する。次いで、高分子量部分を
含有する溶液のPHを2.5〜4.0に調整し、生ずる沈
殿物を分取し遮光して乾燥する。
After the reaction is complete, add a large amount of water to the reaction solution to adjust the pH.
If the concentration is adjusted to 2.5 to 4.0, a precipitate will form, which is removed and thoroughly washed with water to remove the organic solvent. The obtained powder was dissolved in a 0.1N aqueous sodium hydroxide solution, left at room temperature for 5 to 60 minutes, the pH was adjusted to 7.0 to 7.5, and the low molecular weight portion was removed using an ultrafiltration membrane with a molecular weight cutoff of approximately 5000. Remove. Next, the pH of the solution containing the high molecular weight portion is adjusted to 2.5 to 4.0, and the resulting precipitate is collected and dried while shielding from light.

使用に際しては、乾燥粉末を0.1N水酸化ナト
リウム水溶液に溶解し、中和後、0.22μのフイル
ターを通し除菌後、使用する。
Before use, dissolve the dry powder in a 0.1N aqueous sodium hydroxide solution, neutralize it, and pass it through a 0.22μ filter to sterilize it before use.

以上のようにして得られるポルフイリンポリマ
ーは、 次式(): (式中、Xは前述のY及び/又はZに由来する
結合基を表わす。) で示される繰返し単位からなり、高速液体クロマ
トグラフイー又はゲル過法による分子量が約
2000以上(重合度が3以上であるポリマーに相当
する)である。
The porphyrin polymer obtained in the above manner has the following formula (): (In the formula, X represents a bonding group derived from the above-mentioned Y and/or Z.)
2000 or more (corresponds to a polymer with a degree of polymerization of 3 or more).

[発明の効果] 本発明によれば、従来品に比し、低用量で充分
な感受性を示し、腫瘍細胞に特異的な親和性を有
する安全性の高い光感受性物質を提供することが
できる。
[Effects of the Invention] According to the present invention, it is possible to provide a highly safe photosensitizer that exhibits sufficient sensitivity at a lower dose than conventional products and has specific affinity for tumor cells.

[発明の実施例] 以下、実施例、比較例及び試験例により本発明
を更に詳細に説明するが、これらは、本発明の範
囲を何ら制限するものではない。
[Examples of the Invention] Hereinafter, the present invention will be explained in more detail with reference to Examples, Comparative Examples, and Test Examples, but these are not intended to limit the scope of the present invention in any way.

実施例 1 Hp1gのジメチルホルムアミド100ml溶液を、
遮光下、窒素ガスで置換しながら、130〜135℃で
17時間加熱した。反応終了後、反応液に水500ml
を加え、塩酸でPH3.5に調整した。生じた沈殿物
を取し、充分に水洗後、0.1N水酸化ナトリウ
ム水溶液50mlに溶解し、室温で10分放置した。塩
酸でPH7.3に調整し、分画分子量5000の限外過
膜を低分子量部分を除去した後、高分子量部分を
含有する溶液を塩酸でPH3.5に調整して沈殿物を
取してポルフイリンポリマー(以下「N−
HpD−A」という)570mgを得た。
Example 1 A solution of 1 g of Hp in 100 ml of dimethylformamide,
Heat at 130 to 135℃ while replacing with nitrogen gas under light shielding.
Heated for 17 hours. After the reaction is complete, add 500ml of water to the reaction solution.
was added and the pH was adjusted to 3.5 with hydrochloric acid. The resulting precipitate was collected, thoroughly washed with water, dissolved in 50 ml of 0.1N aqueous sodium hydroxide solution, and allowed to stand at room temperature for 10 minutes. After adjusting the pH to 7.3 with hydrochloric acid and removing the low molecular weight portion using an ultrafiltration membrane with a molecular weight cutoff of 5000, the solution containing the high molecular weight portion was adjusted to pH 3.5 with hydrochloric acid and the precipitate was removed. Porphyrin polymer (hereinafter referred to as “N-
570 mg of HpD-A was obtained.

実施例 2 Hp1gを実施例1と同じようにジメチルホルム
アミド100mlに溶解し130〜135℃で8時間及び10
時間反応させてポルフイリンポリマーをそれぞれ
850mg及び700mg得た(以下10時間反応したポルフ
イリンポリマーを「N−HpD−B」といい、8
時間反応したポルフイリンポリマーを「N−
HpD−C」という)。
Example 2 1 g of Hp was dissolved in 100 ml of dimethylformamide in the same manner as in Example 1 and incubated at 130-135°C for 8 hours and 10 hours.
Each porphyrin polymer is reacted for an hour.
850 mg and 700 mg were obtained (hereinafter, the porphyrin polymer reacted for 10 hours is referred to as "N-HpD-B",
The time-reacted porphyrin polymer was
HpD-C”).

実施例 3 Pp1gを実施例1と同じようにジメチルホルム
アミド10mlに溶解し130〜135℃で17時間反応させ
てポルフイリンポリマー(以下「N−HpD−D」
という)600mgを得た。
Example 3 In the same manner as in Example 1, 1 g of Pp was dissolved in 10 ml of dimethylformamide and reacted at 130 to 135°C for 17 hours to form a porphyrin polymer (hereinafter referred to as "N-HpD-D").
) 600 mg.

実施例 4 Hp100mgを酢酸90ml及び濃硫酸10mlの混合溶液
に溶解し、遮光下、窒素ガスで置換しながら、
100℃で1時間加熱した。反応終了後、反応液を
実施例1に準じて処理してポルフイリンポリマー
(以下「N−HpD−E」という)70mgを得た。
Example 4 100 mg of Hp was dissolved in a mixed solution of 90 ml of acetic acid and 10 ml of concentrated sulfuric acid, and the mixture was replaced with nitrogen gas while shielding from light.
Heated at 100°C for 1 hour. After the reaction was completed, the reaction solution was treated according to Example 1 to obtain 70 mg of porphyrin polymer (hereinafter referred to as "N-HpD-E").

実施例 5 Pp100mgを酢酸90ml及び濃硫酸10mlの混合溶液
に溶解し、遮光下、窒素ガスで置換しながら、50
℃で20時間加熱した。反応終了後、反応液を実施
例1に準じて処理してポルフイリンポリマー(以
下「N−HpD−F」という)50mgを得た。
Example 5 100 mg of Pp was dissolved in a mixed solution of 90 ml of acetic acid and 10 ml of concentrated sulfuric acid, and the mixture was heated for 50 ml while replacing the water with nitrogen gas in the dark.
Heated at ℃ for 20 hours. After the reaction was completed, the reaction solution was treated according to Example 1 to obtain 50 mg of porphyrin polymer (hereinafter referred to as "N-HpD-F").

実施例 6 Hp1gのジメチルホルムアミド10ml溶液に濃硫
酸1mlを加えて遮光下、窒素ガスで置換しなが
ら、100℃で60分加熱した。反応終了後、反応液
を実施例1に準じて処理してポルフイリンポリマ
ー(以下「N−HpD−G」という)700mgを得
た。
Example 6 1 ml of concentrated sulfuric acid was added to a solution of 1 g of Hp in 10 ml of dimethylformamide, and heated at 100° C. for 60 minutes while purging with nitrogen gas while shielding from light. After the reaction was completed, the reaction solution was treated according to Example 1 to obtain 700 mg of porphyrin polymer (hereinafter referred to as "N-HpD-G").

実施例 7 Hp(二塩酸塩)4gを氷酢酸76mlと濃硫酸4ml
の混合液に溶解し、室温で5時間放置した。これ
を1.2Lの3%酢酸ナトリウム水溶液に添加し、生
じた沈殿を濾取し、十分に洗浄して乾燥し、粉末
3.4gを得た。得られた粉末100mgを0.1N水酸化ナ
トリウム水溶液5mlに溶解し、室温で1時間処理
した。この溶液に塩酸を加えてPH4.0とし、テト
ラヒドロフラン20ml及び飽和食塩水200mlで洗浄
した。次いで酢酸エチル300mlで抽出し、水洗し
た後、濃縮乾固して粉末を得た。この粉末を高速
液体クロマトグラフイー(Zorbax column;溶
出溶媒、テトラヒドロフラン:水=1:1(V/
V)+10%酢酸塩緩衝液)で分析したところ、以
下の組成であつた。
Example 7 4g of Hp (dihydrochloride) was mixed with 76ml of glacial acetic acid and 4ml of concentrated sulfuric acid.
It was dissolved in a mixed solution of and left at room temperature for 5 hours. Add this to 1.2L of 3% sodium acetate aqueous solution, collect the resulting precipitate by filtration, thoroughly wash and dry, and powder
3.4g was obtained. 100 mg of the obtained powder was dissolved in 5 ml of 0.1N aqueous sodium hydroxide solution and treated at room temperature for 1 hour. Hydrochloric acid was added to this solution to adjust the pH to 4.0, and the solution was washed with 20 ml of tetrahydrofuran and 200 ml of saturated saline. Next, the mixture was extracted with 300 ml of ethyl acetate, washed with water, and concentrated to dryness to obtain a powder. This powder was subjected to high performance liquid chromatography (Zorbax column; elution solvent, tetrahydrofuran:water = 1:1 (V/
V)+10% acetate buffer), the composition was as follows.

Hp:40% 7(12)−(1−ヒドロキシエチル)−12(7)−ビニル
ジユーテロポルフイリン異性体:45% Pp:5% 上記の粉末50mgを実施例1と同様にジメチルホ
ルムアミド5mlに溶解し、130〜135℃で6時間反
応させ、精製してポルフイリンポリマー(以下
「N−HpD−H」という)40mgを得た。
Hp: 40% 7(12)-(1-hydroxyethyl)-12(7)-vinyldeuteroporphyrin isomer: 45% Pp: 5% Add 50 mg of the above powder to 5 ml of dimethylformamide in the same manner as in Example 1. The mixture was dissolved, reacted at 130 to 135°C for 6 hours, and purified to obtain 40 mg of porphyrin polymer (hereinafter referred to as "N-HpD-H").

N−HpD−Hのマススペクトルを測定したと
ころ、ポルフイリン環を3個以上含む重合体であ
ることが確認された。
When the mass spectrum of N-HpD-H was measured, it was confirmed that it was a polymer containing three or more porphyrin rings.

比較例 文献(Cancer Research,38,2628(1978)記
載の方法、即ち「Hpを酢酸及び硫酸と反応させ
一夜放置し、WhatmanNo.1フイルターを用いて
過し、この溶液に酢酸ナトリウムを加え中和
し、生じた沈澱物を減圧乾燥する」に準じて
HpDを得た。更に、このHpD1gを0.1N水酸化
ナトリウム水溶液に溶解し、この溶液をPH9.5に
調整したものを分画分子量10000の限外過膜
(アミコン社製、PM10)を用いて低分子量部分
を除いた高分子画分(以下「IN−HpD」という)
600mgを得た。
Comparative Example The method described in the literature (Cancer Research, 38 , 2628 (1978)), namely, ``Hp was reacted with acetic acid and sulfuric acid, left overnight, filtered using a Whatman No. 1 filter, and neutralized by adding sodium acetate to this solution. and dry the resulting precipitate under reduced pressure.
Got HpD. Furthermore, 1 g of this HpD was dissolved in a 0.1N aqueous sodium hydroxide solution, and this solution was adjusted to pH 9.5, and the low molecular weight portion was removed using an ultrafiltration membrane with a molecular weight cutoff of 10,000 (manufactured by Amicon, PM10). high molecular weight fraction (hereinafter referred to as “IN-HpD”)
Got 600mg.

試験例 1 実施例1及び2で調製した本発明品N−HpD
−A(―〇―,N−HpD−B(―×―),N−HpD−
C(―○†ぁ宗法と羈嗄磴把汗修靴
Test Example 1 Inventive product N-HpD prepared in Examples 1 and 2
-A(-〇-, N-HpD-B(-×-), N-HpD-
C

Claims (1)

【特許請求の範囲】 1 次式(): (式中、Y及びZは、同一でも異なつていても
よく、それぞれ−CH(CH3)OH又は−CH=
CH2を表わす。) で示される化合物からなる群から選ばれた1種の
化合物又は2種以上の化合物の混合物を有機溶媒
中において、光と酸素を遮断して40〜200℃で加
熱反応させることを特徴とする、 次式(): (式中、Xは式()のY及び/又はZに由来
する結合基を表わす。) で示される繰り返し単位からなり、重合度が3以
上であるポルフイリンポリマーの製造法。 2 前記式()で示される化合物からなる群か
ら選ばれた1種の化合物又は2種以上の化合物の
混合物を、酸の不存在下に100〜150℃で加熱反応
させる特許請求の範囲第1項記載の製造法。 3 前記式()で示される化合物からなる群か
ら選ばれた1種の化合物又は2種以上の化合物の
混合物を、酸の存在下に40〜200℃で加熱反応さ
せる特許請求の範囲第1項記載の製造法。
[Claims] Primary formula (): (In the formula, Y and Z may be the same or different, and each represents -CH( CH3 )OH or -CH=
Represents CH2 . ) is characterized by heating and reacting one compound or a mixture of two or more compounds selected from the group consisting of the compounds shown in an organic solvent at 40 to 200°C while blocking light and oxygen. , the following formula (): (In the formula, X represents a bonding group derived from Y and/or Z in the formula ().) A method for producing a porphyrin polymer comprising repeating units represented by the following and having a degree of polymerization of 3 or more. 2. Claim 1, in which one type of compound or a mixture of two or more types of compounds selected from the group consisting of compounds represented by the formula () is heated and reacted at 100 to 150°C in the absence of an acid. Manufacturing method described in section. 3. Claim 1, wherein one type of compound or a mixture of two or more types of compounds selected from the group consisting of compounds represented by the formula () is heated and reacted at 40 to 200°C in the presence of an acid. Manufacturing method described.
JP60085439A 1985-04-23 1985-04-23 Porphyrin polymer Granted JPS61246232A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60085439A JPS61246232A (en) 1985-04-23 1985-04-23 Porphyrin polymer

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60085439A JPS61246232A (en) 1985-04-23 1985-04-23 Porphyrin polymer

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP61116254A Division JPS6263586A (en) 1986-05-22 1986-05-22 Porphyrin polymer

Publications (2)

Publication Number Publication Date
JPS61246232A JPS61246232A (en) 1986-11-01
JPH0554489B2 true JPH0554489B2 (en) 1993-08-12

Family

ID=13858890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60085439A Granted JPS61246232A (en) 1985-04-23 1985-04-23 Porphyrin polymer

Country Status (1)

Country Link
JP (1) JPS61246232A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5493017A (en) * 1992-08-14 1996-02-20 The Trustees Of The University Of Pennsylvania Ring-metalated porphyrins

Also Published As

Publication number Publication date
JPS61246232A (en) 1986-11-01

Similar Documents

Publication Publication Date Title
DE69922216T2 (en) PORPHYRINE DERIVATIVES, THEIR USE IN PHOTODYNAMIC THERAPY AND MEDICAL DEVICES CONTAINING THEREOF
EP0120054B1 (en) Purified hematoporphyrin derivative for diagnosis and treatment of tumors, and method
US5330741A (en) Long-wavelength water soluble chlorin photosensitizers useful for photodynamic therapy and diagnosis of tumors
DK167769B1 (en) FLUORESCING MONO, DI OR POLYAMIDES OF AN AMINODICARBOXYLIC ACID AND A TETRAPYRROL COMPOUND CONTAINING THREE CARBOXYL GROUPS AND PROCEDURES FOR PREPARING THEREOF
DE60103697T2 (en) Langwelligabsorbierende bacteriochlorin alkyl-ether analogues
EP1066293B1 (en) New porphyrins and their use
CA2268968C (en) Iminochlorin aspartic acid derivatives
EP0659407B1 (en) Pharmaceutical compositions containing pyrylium compounds, pyrylium salts and process for manufacturing a medicament containing the aforesaid compounds
DE69913351T2 (en) Metal complexes of chlorine derivatives for X-ray shielding
JPH0551613B2 (en)
JPWO2008102669A1 (en) Novel sugar-linked chlorin derivative and method for producing the same
Faustino et al. Meso‐Tetraphenylporphyrin Dimer Derivative as a Potential Photosensitizer in Photodynamic Therapy
CN112409365A (en) 3-sulfopropane sulfydryl modified phthalocyanine, preparation method thereof and application thereof in pharmaceutical field
JPH0554489B2 (en)
EP2072584B1 (en) Phthalocyanine dyes, their preparation and use
JPH0466873B2 (en)
AU773261B2 (en) Porphyrin compound
JP2021528482A (en) Oxazine compounds and their use
EP0322198B1 (en) Pheophorbide derivatives
JP3718887B2 (en) Porphyrin derivatives and their uses
US5789586A (en) Efficient functionalization of porphyrin derivatives possessing sulfonic acid groups
JPH0680671A (en) Porphyrin dimer and its use
CN113717183B (en) Phthalocyanine modified by pericyclic asymmetric arginine, preparation thereof and application thereof in pharmaceutical field
JPS62167783A (en) Porphyrin derivative
CN115557971B (en) Organic fluorescent small molecular compound for imaging above 1500nm, and preparation method and application thereof